Arno M. Wiersema

ORCID: 0000-0001-6045-9022
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac, Anesthesia and Surgical Outcomes
  • Aortic aneurysm repair treatments
  • Vascular Procedures and Complications
  • Venous Thromboembolism Diagnosis and Management
  • Peripheral Artery Disease Management
  • Aortic Disease and Treatment Approaches
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Infectious Aortic and Vascular Conditions
  • Cardiac and Coronary Surgery Techniques
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Imaging and Diagnostics
  • Cardiac Ischemia and Reperfusion
  • Acute Ischemic Stroke Management
  • Coronary Interventions and Diagnostics
  • Diagnosis and Treatment of Venous Diseases
  • Abdominal Surgery and Complications
  • Vascular anomalies and interventions
  • Hemodynamic Monitoring and Therapy
  • Hip and Femur Fractures
  • Diabetic Foot Ulcer Assessment and Management
  • Acute Myocardial Infarction Research
  • Soft tissue tumor case studies
  • Abdominal vascular conditions and treatments
  • Sarcoma Diagnosis and Treatment
  • Tumors and Oncological Cases

Amsterdam University Medical Centers
2019-2024

Westfriesgasthuis
2012-2024

Reinier de Graaf Hospital
2021-2024

Vrije Universiteit Amsterdam
2023-2024

Refaja Ziekenhuis
2019-2023

Leiden University Medical Center
2018-2022

Dutch Institute for Clinical Auditing
2020-2022

Leiden University
2022

The Netherlands Cancer Institute
2022

University of Amsterdam
2019-2021

OBJECTIVE Conflicting evidence exists on the effects of hyperbaric oxygen therapy (HBOT) in treatment chronic ischemic leg ulcers. The aim this trial was to investigate whether additional HBOT would benefit patients with diabetes and RESEARCH DESIGN AND METHODS Patients an wound (n = 120) were randomized standard care (SC) without or (SC+HBOT). Primary outcomes limb salvage healing after 12 months, as well time healing. Other end points amputation-free survival (AFS) mortality. RESULTS Both...

10.2337/dc17-0654 article EN Diabetes Care 2017-10-26
Mark J.W. Koelemay Nick S. van Reijen Susan van Dieren F.A. Frans Erik J.G. Vermeulen and 89 more H.C.J.L. Buscher Jim A. Reekers Marcel G. W. Dijkgraaf Rob J. de Haan Ron Balm Mirza M. Idu Jan D. Blankensteijn Arjan W.J. Hoksbergen A.P. Conijn Rosemarie Met D.A. Legemate Shandra Bipat Krijn P. van Lienden Otto M. van Delden Emma Zijlstra Krijn P. van Lienden Rutger J. Lely R.H.H. Engelbert M.A. van Egmond A E van Poelgeest Edwin Geleijn Anliu Nie Michiel A. Schreve Alfons G. A. Kamphuis R.H. Kropman Jan Wille J.P.M.M. de Vries R.H. van de Mortel H.D. van de Pavoord Daniel A van den Heuvel Marc van Leersum Marco J. van Strijen J.A. Vos D. Nio A. Rijbroek G.J. Akkersdijk R. Metz B.J. van Kelckhoven H.J. van de Rest V.J. Leijdekkers A.C. Vahl R.C. van Nieuwenhuizen J G M Blomjous Alexander D. Montauban van Swijndregt P.P.C. Poyck M. van der Jagt J.A. van der Vliet Leo J. Schultze Kool Peter Klemm H.W. Slis M.C. Willems L.C. Huisman J.H.D. de Bruine M.J. Mallant L. Smeets S.M. van Sterkenburg Michel M.P.J. Reijnen P.B. Veendrick M.H. van Werkum J.A. van Ostayen B.H. Elsman L.G. van der Hem R.B.M. van Tongeren C.F.M. Klok Willem E. Hellings J.C.N.M. Aarts Arno M. Wiersema T.A. van den Broek A. Moolhuijzen Joep A.W. Teijink M.R. van Sambeek Birgit Keller G.A. Vos J.C. Breek J. Gravendeel Richard Oosterhof-Berktas N.A. Koedam E.J. Hollander T. Pels Rijcken S.S. van der Voort B. Honing D.M. Scharn M.S. Lemson Jan Seegers R.M. Krol Christianne J. Buskens C.J. Zeebregts Rob A. de Bie Hans van Overhagen

ObjectiveInternational guidelines recommend supervised exercise therapy (SET) as primary treatment for all patients with intermittent claudication (IC), yet endovascular revascularisation (ER) might be more effective in iliac artery obstruction.MethodsThis was a multicentre RCT including IC caused by stenosis or occlusion (NCT01385774). Patients were allocated randomly to SET ER stratified maximum walking distance (MWD) and concomitant SFA disease. Primary endpoints MWD on treadmill (3.2...

10.1016/j.ejvs.2021.09.042 article EN cc-by European Journal of Vascular and Endovascular Surgery 2022-02-10

To determine the safety and efficacy of treating abdominal aortic aneurysm (AAA) sacs with polyurethane shape memory polymer (SMP) devices during endovascular repair (EVAR), using a technique to fully treat target lumen after endograft placement (aortic flow volume minus volume). SMP self-expand in sac form porous scaffold that supports thrombosis throughout its structure.

10.1016/j.jvs.2023.12.045 article EN cc-by-nc-nd Journal of Vascular Surgery 2024-01-05

Females are more prone to complications during non-cardiac arterial procedures (NCAPs) than males. The current study investigated the difference in effect of peri-procedural prophylactic heparin males and females, using activated clotting time (ACT). This was a retrospective analysis prospective multicentre cohort study.All patients undergoing elective NCAP ACT measurements between January 2016 March 2020 were included. Two dosage protocols used: weight based dosing 100 IU/kg (international...

10.1016/j.ejvs.2022.08.005 article EN cc-by European Journal of Vascular and Endovascular Surgery 2022-08-13

In non-cardiac arterial procedures (NCAP), heparin is administered to prevent thromboembolic complications (ATEC). Heparin has a nonpredictable effect in the individual patient, also known as variation sensitivity. Various dosing protocols are use, but optimal dose currently still unknown. A standardized bolus of 5 000 IU most frequently used by vascular surgeons and interventional radiologists. The activated clotting time (ACT) an established method measure level anticoagulation, has, until...

10.1016/j.avsg.2020.07.035 article EN cc-by-nc-nd Annals of Vascular Surgery 2020-08-05
Michael Sweeting Pinar Ulug Joy Roy Rebecka Hultgren Reza Indrakusuma and 95 more Ron Balm Matt Thompson Robert J. Hinchliffe Simon G. Thompson Janet T. Powell Ron Balm Mark J.W. Koelemay Mirza M. Idu C. Kox D.A. Legemate L.C. Huisman M.C. Willems Jim A. Reekers Otto M. van Delden Krijn P. van Lienden L.L. Hoornweg J.J. Reimerink S.C. van Beek A.C. Vahl V.J. Leijdekkers Hans Bosma Alexander D. Montauban van Swijndregt C de Vries Victor P. M. van der Hulst Jan Peringa J. G. A. M. Blomjous M.J. Visser F.H.W.M. van der Heijden Willem Wisselink Arjan W.J. Hoksbergen Jan D. Blankensteijn M T J Visser H.M.E. Coveliers J.H. Nederhoed F.G. van den Berg Bram B. van der Meijs Mijntje L.P. van den Oever Rutger J. Lely Martijn R. Meijerink Iris M. Westra A Voorwinde Jan M. Ultee R.C. van Nieuwenhuizen Boudewijn J. Dwars T O M Nagy P L Tolenaar Arno M. Wiersema James A. Lawson P.J. van Aken A A Stigter Theodore A.A. van den Broek G.A. Vos W. Mulder R.P. Strating D. Nio G.J. Akkersdijk A. van der Elst P van Exter Pascal Desgranges J.-P. Becquemin Éric Allaire Frédéric Cochennec J. Marzelle Nicolas Louis J. Schneider Michał Majewski Yves Castier Guy Lesèche Febin Francis Éric Steinmetz J-P Berne Claire Favier Stéphan Haulon Mohamed Koussa Richard Azzaoui D Piervito Yves Alimi Mourad Boufi Olivier Hartung P Cerquetta Philippe Amabile P Piquet J. Penard Matthew DeMasi Pierre Alric L Cannaud J-P Berthet Pierre Julia J.-N. Fabiani Jean-Marc Alsac Pierre Gouny Ali Badra J Braesco J-P Favre J-N Albertini

The aim of this study was to develop a 48-h mortality risk score, which included morphology data, for patients with ruptured abdominal aortic aneurysm presenting an emergency department, and assess its predictive accuracy clinical effectiveness in triaging immediate repair, transfer or palliative care.Data from the IMPROVE (Immediate Management Patient With Ruptured Aneurysm: Open Versus Endovascular Repair) randomized trial were used score. Variables considered age, sex, haemodynamic...

10.1002/bjs.10820 article EN cc-by-nc British journal of surgery 2018-04-06

Unfractionated heparin has an unpredictable effect in individual patient. The activated clotting time (ACT) can be used to measure the of patient and guide additional dosages. Previous cohort studies showed that a standardized bolus 5,000 IU during noncardiac arterial procedures (NCAP) does not lead adequate ACT vast majority patients. aim this study was investigate whether initial dose 100 IU/kg leads but safe ACT, from 200 300 s.In multicenter prospective study, 186 patients undergoing...

10.1016/j.avsg.2022.01.029 article EN cc-by-nc-nd Annals of Vascular Surgery 2022-03-03

Purpose: To describe the successful endovascular treatment of 2 patients with type IIIb endoleak using Nellix EndoVascular Aneurysm Sealing (EVAS) System. Case Report: Two men aged 75 and 83 years presented several (8 3, respectively) after initial aneurysm repair. Dual endoprosthesis were deployed in stent-grafts, endobags filled polymer to seal defect eliminate endoleak. The perioperative periods uneventful. At up 6-month follow-up, no endoleaks detected, diameters unchanged, endografts...

10.1177/1526602815617922 article EN Journal of Endovascular Therapy 2015-11-19

ObjectiveRegular measurement of fibrinogen as dose guidance in catheter directed thrombolysis (CDT) for acute limb ischaemia (ALI) has recently been dropped from European guidelines based on inconsistent literature. This study aimed to determine whether low levels and high activated partial thromboplastin time (APTT) are associated with an increased major bleeding risk during CDT.MethodsAll consecutive patients treated CDT ALI two Dutch hospitals between January 2004 April 2021 were analysed...

10.1016/j.ejvs.2022.11.010 article EN cc-by European Journal of Vascular and Endovascular Surgery 2022-11-05

Abstract The pathophysiology of aortic aneurysms (AA) is far from being understood. One reason for this lack understanding basic research constrained to fixated cells or isolated cell cultures, by which cell-to-cell and cell-to-matrix communications are missed. We present a new, in vitro method extended preservation wall sections study pathophysiological processes. Intraoperatively harvested, live specimens were cut into 150 μm cultured. Viability was quantified up 92 days using...

10.1038/s41598-018-26549-4 article EN cc-by Scientific Reports 2018-05-18
Coming Soon ...